• Home
  • About Us
    • Company Profile
    • Development Process
    • Quality Control
    • Sustainable Development
  • Products
    • RNA monomers & Derivatives
    • DNA monomers & Derivatives
    • Polynucleotide Series
    • Cyclic Nucleotide Series
    • Sugar nucleotide series
    • Other Series
  • Services
    • Custom Services
    • Product Brochure
  • News
    • Company News
    • Industry Trends
  • Contact Us
  • EN
  • CN
  • 끠 Search
    Product ꀁ
    • Product
    • Article

News Dynamics

Provides you with the latest company and industry information

Stay up to date with the latest company news and upcoming events

  • ATP-Na2 in Biofertilizers: Mechanism & Application Guide

    넶0 2025-11-07
  • SCAD: Unlocking a New Era of Duplex RNA Delivery to the Brain and Beyond

    넶0 2025-11-04
  • The Rise of Circular RNA: A NextGeneration Platform for Therapeutics and Vaccines

    Source: Molecular Therapy (October 17, 2025) | Compiled by Industry Watch

    넶0 2025-10-24
  • A Breakthrough in Circular RNA Vaccines: B6M1 Bivalent Immunogen Opens a New Era for Smallpox Virus Vaccine Development

    Source: Cell Reports (October 2025) | Compiled by: Industry Watch

    넶7 2025-10-14
  • What are the biological functions of uridine?

    넶12 2025-05-26
  • The current application status of nucleotides

    Hangzhou Meiya Pharmaceutical Co., Ltd. is a national high-tech enterprise specializing in the research and development, production and sales of nucleotide series products and has GMP and ISO9001 certification. The products cover more than 60 specifications of nucleoside, one phosphorus nucleotide, two phosphorus nucleotide, three phosphorus nucleotide, cyclic nucleotide, polynucleotide, yeast nucleotide, enzyme preparation, etc. The company is committed to the research, production and improveme

    넶35 2025-05-09
  • What are the detection methods for nucleotides?

    nucleotides are the basic building blocks of DNA and RNA and are essential for the normal functioning of life. In the development of modern biotechnology, the production process of nucleotides has been continuously improved to meet the needs of different fields.

    넶13 2025-05-09
  • About Meiya
  • Company Profile
  • Development process
  • Quality Control
  • sustainable development
  • Product Center
  • RNA monomers & Derivatives

  • DNA monomers & Derivatives

  • Polynucleotide Series

  • Cyclic Nucleotide Series

  • Sugar nucleotide series

  • Other Series

  • Custom Solutions

  • Service Support
  • Custom Services
  • Product Brochure
  • Related Links
  • Website
  • News Dynamics
  • Contact Us

Address

Headquarters: Hangzhou Meiya Pharmaceutic

al Co., Ltd.

Room 101, Building 12, Yinhai Science and Tech

nology Innovation Center, 501 Fucheng Road,

Xiasha Street, Qiantang District, Hangzhou City,

Zhejiang Province

 

Sales Company: Shanghai Nucleotide Biotec

hnology Co., Ltd.

 

 

Production base: Meiya Pharmaceutical Hai

an Co., Ltd.

 

Copyright©2025 Hangzhou Meiya Pharmaceutical Co., Ltd.
 本网站由阿里云提供云计算及安全服务
本网站支持 IPv6
 本网站由阿里云提供云计算及安全服务
本网站支持 IPv6
 本网站由阿里云提供云计算及安全服务
本网站支持 IPv6
 本网站由阿里云提供云计算及安全服务
本网站支持 IPv6